These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 26754190)
1. Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome. Vignozzi L; Gacci M; Maggi M Nat Rev Urol; 2016 Feb; 13(2):108-19. PubMed ID: 26754190 [TBL] [Abstract][Full Text] [Related]
2. The Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Mean Platelet Volume: The Role of Metabolic Syndrome. Zhao S; Tang J; Shao S; Yan Y Urol Int; 2016; 96(4):449-58. PubMed ID: 26745140 [TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation. Gacci M; Vignozzi L; Sebastianelli A; Salvi M; Giannessi C; De Nunzio C; Tubaro A; Corona G; Rastrelli G; Santi R; Nesi G; Serni S; Carini M; Maggi M Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):101-6. PubMed ID: 23165431 [TBL] [Abstract][Full Text] [Related]
4. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia]. Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G; Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758 [TBL] [Abstract][Full Text] [Related]
5. Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events. Mirone V; Sessa A; Giuliano F; Berges R; Kirby M; Moncada I Int J Clin Pract; 2011 Sep; 65(9):1005-13. PubMed ID: 21718399 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. Calogero AE; Burgio G; Condorelli RA; Cannarella R; La Vignera S Aging Male; 2019 Mar; 22(1):12-19. PubMed ID: 29392976 [TBL] [Abstract][Full Text] [Related]
8. Benign prostatic hyperplasia and urinary symptoms: Evaluation and treatment. Mobley D; Feibus A; Baum N Postgrad Med; 2015 Apr; 127(3):301-7. PubMed ID: 25823641 [TBL] [Abstract][Full Text] [Related]
9. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship. Lee JH; Kwon H; Park YW Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675 [TBL] [Abstract][Full Text] [Related]
10. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association]. Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A; Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093 [TBL] [Abstract][Full Text] [Related]
12. Metabolically healthy obesity is associated with increased risk of lower urinary tract symptoms secondary to benign prostatic hyperplasia: A cohort study of Chinese elderly males. Chen W; Man S; Wang B; Kadeerhan G; Huang X Low Urin Tract Symptoms; 2022 May; 14(3):170-177. PubMed ID: 34882977 [TBL] [Abstract][Full Text] [Related]
13. Associations of obesity, physical activity and diet with benign prostatic hyperplasia and lower urinary tract symptoms. Raheem OA; Parsons JK Curr Opin Urol; 2014 Jan; 24(1):10-4. PubMed ID: 24247174 [TBL] [Abstract][Full Text] [Related]
14. Current Status of the Relationship Between Metabolic Syndrome and Lower Urinary Tract Symptoms. Sebastianelli A; Gacci M Eur Urol Focus; 2018 Jan; 4(1):25-27. PubMed ID: 29602736 [TBL] [Abstract][Full Text] [Related]
15. Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction. Brock G; Broderick G; Roehrborn CG; Xu L; Wong D; Viktrup L BJU Int; 2013 Nov; 112(7):990-7. PubMed ID: 23937669 [TBL] [Abstract][Full Text] [Related]
16. [How to prevent LUTS due to BPH development and progression]. de la Taille A; Descazeaud A; Robert G Prog Urol; 2018 Nov; 28(15):821-829. PubMed ID: 30262262 [TBL] [Abstract][Full Text] [Related]
17. Lower urinary tract symptoms are associated with low levels of serum serotonin, high levels of adiponectin and fasting glucose, and benign prostatic enlargement. Haghsheno MA; Mellström D; Peeker R; Hammarsten J; Lorentzon M; Sundh V; Karlsson M; Ohlsson C; Damber JE Scand J Urol; 2015 Apr; 49(2):155-61. PubMed ID: 25253423 [TBL] [Abstract][Full Text] [Related]
18. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK. Speakman M; Kirby R; Doyle S; Ioannou C BJU Int; 2015 Apr; 115(4):508-19. PubMed ID: 24656222 [TBL] [Abstract][Full Text] [Related]
19. Inhaled anticholinergic agents and acute urinary retention in men with lower urinary tract symptoms or benign prostatic hyperplasia. Vande Griend JP; Linnebur SA Ann Pharmacother; 2012 Sep; 46(9):1245-9. PubMed ID: 22851743 [TBL] [Abstract][Full Text] [Related]
20. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]